Carl Icahn, one of Wall Street’s fiercest activists, is taking a big swipe next week, as he attempts to unseat the brash CEO of Illumina, the dominant player in the field of gene sequencing.
An error has occurred, please try again later.
Stocks continued their recent selloff on Tuesday amid a slew of concerning headlines for investors.Labor market data showed job openings...
(Bloomberg) — A selloff in global bond markets gathered pace, driving yields to the highest level in more than a...
A woman goes over her estate plan with her daughter, son-in-law and grandchildren.Inheritance trusts take on critical importance in wealth...
(Bloomberg) -- SAS AB chose Air France-KLM and private equity firm Castlelake LP to anchor a $1.18 billion investment in...
